|
Colin S. Duckett, Ph.D. |
|
|
|
|
Research InterestsRegulation
of apoptosis; control of cell survival by the tumor necrosis factor and
transforming growth factor beta-receptor superfamilies. Brief BiographyDr.
Duckett received his Ph.D. from the University of London, England, during
which time he worked with Dr. Gary Nabel at the University of Michigan
on the regulation of HIV by the transcription factor NF-kB. He did postdoctoral
work at the University of Chicago with Dr. Craig Thompson, where he studied
the regulation of apoptosis, before moving to the National Cancer Institute
in 1997 as a principal investigator. He joined the Pathology Department
at the University of Michigan in 2002, where he has a joint appointment
in the Department of Medicine and is a member of the Cancer Center.
Mir,
S. S., Richter, B.W.M. and Duckett, C. S. Differential effects of CD30
activation in anaplastic large cell lymphoma and Hodgkin's disease cells.
Blood 96:4307-4312 (2000). |
|